Top Industry Professional Joins Aphena as Head of Quality & Regulatory Affairs
COOKEVILLE, Tenn., May 13, 2011 /PRNewswire/ -- Cookeville-based Aphena Pharma Solutions Inc., a leading pharmaceutical packaging provider in the U.S., is pleased to announce that on June 1, Mary G. Foster, PharmD — one of the top regulatory professionals in the industry — will join the company as its Corp. VP of Quality and Regulatory Affairs. In this role, Foster will help Aphena to shape its vision, plan long-term goals, and further enhance the company's rigorous adherence to the highest quality and regulatory standards.
A senior-level regulatory/quality professional with more than 25 years of experience, Foster comes to Aphena from Catalent Pharma Solutions, where she served as vice president of quality. In that role, she was responsible for creating a global current Good Manufacturing Practices (cGMP) program and for training and developing connections within the industry and worldwide regulatory bodies to ensure continuous understanding and improvement of quality processes.
"We're so pleased to have Mary join the company. It is our intent to employ the industry's best and brightest, Mary certainly fits that category" said Aphena President and CEO Renard Jackson. "She shares our company's values, our focus on client expectations, and our vision for the future as a single-source industry leader."
"I've been impressed with Aphena's increasing leadership in the pharmaceutical packaging industry in recent years," said Foster. "To me, this was a logical next step in my career, and I am eager to begin working with such a quality-driven team."
Aphena was formed this year as a strategic alliance between Celeste Contract Packaging, PrePak Systems, TestPak and Integrated Pharmaceutical Packaging — all long-term specialized leaders in the contract pharma and personal care packaging, repackaging and manufacturing industry. Aphena offers turnkey solutions for the pharmaceutical, OTC, nutraceutical, animal health, health and beauty, consumer health and medical device markets.
For more information about Aphena and its subsidiaries, visit www.aphenapharma.com.
SOURCE Aphena Pharma Solutions Inc.